ARTICLES BY THIS AUTHOR
- 3/30/2021
Public coverage expands for high-dose flu vaccine
Alberta has become the third province in Canada to fund the Fluzone High-Dose influenza vaccine for all adults aged 65 and older, beginning with 2021-2022 season. - 3/30/2021
Triple combination therapy shows efficacy for CF in children 6-12
The treatment would be the first to address the underlying genetic defect in children belonging to this younger age group. - 3/30/2021
Domestic flu vaccine production gets boost
Sanofi will build a new vaccine manufacturing facility in Toronto, Ontario, to increase the supply of its Fluzone High-Dose quadrivalent influenza vaccine in Canada, the U.S. and Europe.